Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormonal Male Contraception in Men With Normal and Subnormal Semen Parameters
NCT00167141Phase 2Terminated
- Sponsor
- Universitätsklinikum Münster
- Start
- Feb 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of testosterone in contraception, sponsored by Universitätsklinikum Münster. Primary endpoints: Semen parameters at 24 weeks and Rate of azoospermia at 24 weeks. Started Feb 2005; status: terminated.
02
Drugs
testosterone
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00167141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00167141.